Artiva Biotherapeutics (ARTV) Other Non Operating Income (2023 - 2026)

Artiva Biotherapeutics (ARTV) has 4 years of Other Non Operating Income data on file, last reported at $2000.0 in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $2000.0, up 150.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $6000.0 (down 99.57% YoY), and the FY2024 annual result was $157000.0, down 19.49% from the prior year.
• Other Non Operating Income slipped to $2000.0 in Q1 2026 per ARTV's latest filing, from $12000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $3.8 million in Q4 2024 and troughed at -$2.4 million in Q2 2024.
• A 4-year average of $149500.0 and a median of $7000.0 in 2025 frame the typical range for Other Non Operating Income.
• On a YoY basis, Other Non Operating Income climbed as much as 2134.52% in 2024 and fell as far as 7687.1% in 2024.
• A 4-year view of Other Non Operating Income shows it stood at $168000.0 in 2023, then jumped by 2134.52% to $3.8 million in 2024, then sank by 99.68% to $12000.0 in 2025, then tumbled by 83.33% to $2000.0 in 2026.
• Business Quant data shows ARTV's Other Non Operating Income at $2000.0 in Q1 2026, $12000.0 in Q4 2025, and -$3000.0 in Q3 2025.